No Difference in Penetrance between Truncating and Missense/Aberrant Splicing Pathogenic Variants in MLH1 and MSH2: A Prospective Lynch Syndrome Database StudyMev Dominguez–Valentin, Wolff Schmiegel, Stefan Aretz et al.|Journal of Clinical Medicine|2021Cited by 20
No Difference in Penetrance between Truncating and Missense/Aberrant Splicing Pathogenic Variants in MLH1 and MSH2: A Prospective Lynch Syndrome Database StudyMev Dominguez–Valentin, Jürgen Weitz, John‐Paul Plazzer et al.|Kölner Universitäts PublikationsServer (Universität zu Köln)|2021Cited by 0